NatureWise Biotech & Medicals Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
NatureWise Biotech & Medicals has a total shareholder equity of NT$641.9M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$700.9M and NT$59.0M respectively. NatureWise Biotech & Medicals's EBIT is NT$8.0M making its interest coverage ratio -1.3. It has cash and short-term investments of NT$493.9M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
NT$0
Schuld
| Rente dekkingsratio | -1.3x |
| Contant | NT$493.91m |
| Aandelen | NT$641.93m |
| Totaal verplichtingen | NT$58.98m |
| Totaal activa | NT$700.91m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20
Analyse van de financiële positie
Kortlopende schulden: 4732's short term assets (NT$630.2M) exceed its short term liabilities (NT$50.6M).
Langlopende schulden: 4732's short term assets (NT$630.2M) exceed its long term liabilities (NT$8.4M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 4732 is debt free.
Schuld verminderen: 4732 has not had any debt for past 5 years.
Schuldendekking: 4732 has no debt, therefore it does not need to be covered by operating cash flow.
Rentedekking: 4732 has no debt, therefore coverage of interest payments is not a concern.